Avidity Biosciences, Inc. Common Stock
XNAS:RNA
71.7
$72.00 - 100.00
$10.00 - 1.00
$71.57
$71.78
$71.59
$71.56
71.78
21.51
1070822
2671001.7
138118210.13
Chart
TendieTensor AI Analysis
Company
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.
Fundamentals
391
-17.190000
5.579000
-1.27
100
BBG00FQ7LXW1
BBG00FQ7LXX0
145.90M
146.91M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own RNA. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.